SCHEMBL2263255

SCHEMBL2263255

COc1ccc(/C=N/[O])cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
CYP2A6 P11509 1/20 0.58
CYP1A2 P05177 1/20 0.55
GRIN2D O15399 2/20 0.53
GRIN3B O60391 2/20 0.53
GRIN1 Q05586 2/20 0.53
GRIN2A Q12879 2/20 0.53
GRIN2B Q13224 2/20 0.53
GRIN2C Q14957 2/20 0.53
GRIN3A Q8TCU5 2/20 0.53
KMT2A Q03164 2/20 0.53
POLB P06746 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
S100B P04271 1/20 0.52
CA12 O43570 2/20 0.50
CA2 P00918 2/20 0.50
CA9 Q16790 2/20 0.50
LMNA P02545 1/20 0.50
TP53 P04637 1/20 0.50
CYP3A4 P08684 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2263257 1.00 ALDH1A1 (0.58) ALDH1A1CYP2A6CYP1A2GRIN2DGRIN3B
SCHEMBL11776228 0.81 GRIN2D (0.68) ALDH1A1CYP2A6CYP1A2GRIN2DGRIN3B
SCHEMBL269159 0.81 GRIN2D (0.68) ALDH1A1CYP2A6CYP1A2GRIN2DGRIN3B
SCHEMBL11207836 0.79 GRIN2D (0.55) ALDH1A1CYP2A6CYP1A2GRIN2DGRIN3B
SCHEMBL10374800 0.79 GRIN2D (0.55) ALDH1A1CYP2A6CYP1A2GRIN2DGRIN3B
SCHEMBL7731054 0.78 ALDH1A1 (0.54) ALDH1A1CYP2A6CYP1A2GRIN2DGRIN3B
SCHEMBL1963947 0.77 GRIN2D (0.53) ALDH1A1CYP2A6CYP1A2GRIN2DGRIN3B
SCHEMBL3971293 0.77 GRIN2D (0.58) ALDH1A1CYP2A6CYP1A2GRIN2DGRIN3B
SCHEMBL1566907 0.77 KMT2A (0.69) ALDH1A1CYP2A6CYP1A2GRIN2DGRIN3B
SCHEMBL6077468 0.77 GRIN2D (0.53) ALDH1A1CYP2A6CYP1A2GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110201603-A1 Novel Acylaminobenzamide Derivatives BAYER CROPSCIENCE AG (DE) 2011-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110201603-A1 Novel Acylaminobenzamide Derivatives KCNB1, KCNA5, KCNA7 ALDH1A1 271/4885CYP2A6 240/4885CYP1A2 126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.